Mon-Fri 9:00-18:00 CET+39 095 7211344info@vitasanlabs.com

Family · Pharmaceutical analytical standards

Fosinopril

An ACE inhibitor used for hypertension and heart failure, patented in 1980 and approved in 1991: it is a prodrug that the liver and gut lining convert into the active form, fosinoprilat. This family brings together the active ingredient, pharmacopoeial impurities, labelled standards, nitrosamines and other impurities.

Did you know?It is the only marketed ACE inhibitor that contains phosphorus and, unlike most of its relatives, it is eliminated by both the kidneys and the liver.

Fosinopril sodium saltGo to the active ingredient →
FosinoprilatPharmacopoeial impurityFosinoprilatCat. No. P-F122-009CAS 95399-71-6

EDQM standards 7

The official European Pharmacopoeia standards for this family.

Need a molecule you cannot find?

Custom synthesis of impurities, metabolites and labelled compounds, with the same characterisation level.